Spinal Muscular Atrophy: Present State

Henning Schmalbruch; Georg Haase

doi:10.1111/j.1750-3639.2001.tb00395.x

. 2006 Apr 5;11(2):231–247. doi: 10.1111/j.1750-3639.2001.tb00395.x

Spinal Muscular Atrophy: Present State

Henning Schmalbruch ^1,^✉, Georg Haase ²

PMCID: PMC8098133 PMID: 11303798

Abstract

Spinal muscular atrophy (SMA) is a hereditary neurodegenerative disease caused by homozygous deletions or mutations in the SMN1 gene on Chr.5q13. SMA spans from severe Werdnig‐Hoffmann disease (SMA 1) to relatively benign Kugelberg‐Welander disease (SMA 3). Onset before birth possibly aggravates the clinical course, because immature motoneurons do not show compensatory sprouting and collateral reinnervation, and motor units in SMA 1, in contrast to those in SMA 3, are not enlarged. Genetic evidence indicates that SMN2, a gene 99% identical to SMN1, can attenuate SMA severity: in patients, more SMN2 copies and higher SMN protein levels are correlated with milder SMA. There is evidence that SMN plays a role in motoneuron RNA metabolism, but it has also been linked to apoptosis.

Several mouse models with motoneuron disease have been successfully treated with neurotrophic factors. None of these models is, however, homologous to SMA. Recently, genetic mouse models of SMA have been created by introducing human SMN2 transgenes into Smn knockout mice or by targeting the Smn gene knockout to neurons. These mice not only provide important insights into the pathogenesis of SMA but are also crucial for testing new therapeutic strategies. These include SMN gene transfer, molecules capable to up‐regulate SMN expression and trophic or antiapoptotic factors.

Full Text

The Full Text of this article is available as a PDF (759.3 KB).

References

1. Akli S, Caillaud C, Vigne E, Stratford PL, Poenaru L, Perricaudet M, Kahn A, Peschanski MR. (1993) Transfer of a foreign gene into the brain using adenovirus vectors. Nat Genet 3: 224–228. [DOI] [PubMed] [Google Scholar]
2. Azzouz M, Hottinger A, Paterna JC, Zurn AD, Aebischer P, Bueler H (2000) Increased motoneuron survival and improved neuromuscular function in transgenic ALS mice after intraspinal injection of an adeno‐associated virus encoding Bcl‐2. Hum Mol Genet 9: 803–811. [DOI] [PubMed] [Google Scholar]
3. Battaglia G, Princivalle A, Forti F, Lizier C, Zeviani M. (1997) Expression of the SMN gene, the spinal muscular atrophy determining gene, in the mammalian central nervous system. Hum Mol Genet 6: 1961–1971. [DOI] [PubMed] [Google Scholar]
4. Béchade C, Rostaing P, Cisterni C, Kalisch R, La Bella V, Pettmann B, Triller A. (1999) Subcellular distribution of survival motor neuron (SMN) protein: possible involvement in nucleocytoplasmic and dendritic transport. Eur J Neurosci 11: 293–304. [DOI] [PubMed] [Google Scholar]
5. Betz WJ, Caldwell JH, Ribchester RR (1980) The effects of partial denervation at birth on the development of muscle fibres and motor units in rat lumbrical muscle. J Physiol (Lond) 303: 265–279. [DOI] [PMC free article] [PubMed] [Google Scholar]
6. Biral D, Scarpini E, Angelini C, Salviati G, Margreth A (1989) Myosin heavy chain composition of muscle fibers in spinal muscular atrophy. Muscle Nerve 12: 43–51. [DOI] [PubMed] [Google Scholar]
7. Bledsoe AW, Jackson CA, McPherson S, Morrow CD (2000) Cytokine production in motor neurons by poliovirus replicon vector gene delivery. Nat Biotechnol 18: 964–969. [DOI] [PubMed] [Google Scholar]
8. Brahe C, Clermont O, Zappata S, Tiziano F, Melki J, Neri G. (1996) Frameshift mutation in the survival motor neuron gene in a severe case of SMA type I. Hum Mol Genet 5: 1971–1976. [DOI] [PubMed] [Google Scholar]
9. Brännström T, Kellerth J‐O (1998) Changes in synaptology of adult cat spinal alpha‐motoneurons after axotomy. Exp Brain Res 118: 1–13. [DOI] [PubMed] [Google Scholar]
10. Braun S, Croizat B, Lagrange MC, Warter JM, Poindron P (1995) Constitutive muscular abnormalities in culture in spinal muscular atrophy. Lancet 345:694–695. [DOI] [PubMed] [Google Scholar]
11. Bronson RT, Lake BD, Cook S, Taylor S, Davisson MT (1993) Motor neuron degeneration in mice is a model of neuronal ceroid lipofuscinosis (Batten's disease). Annals of Neurology 33: 381–385. [DOI] [PubMed] [Google Scholar]
12. Brown MC, Jansen JKS, Van Essen D (1976) Polyneural inervation of skeletal muscle in new‐born rats and its elimination during maturation. J Physiol (Lond) 261: 387–422. [DOI] [PMC free article] [PubMed] [Google Scholar]
13. Brzustowicz LM, Lehner T, Castilla LH, Penchaszadeh GK, Wilhelmsen KC, Daniels R, Davies KE, Leppert M, Ziter F, Wood D, Dubowitz V, Zerres K, Hausmanowa‐Petrusewicz I, Ott J, Munsat TL, Gilliam TC (1990) Genetic mapping of chronic childhood onset spinal muscular atrophy to chromosome 5q11.2–13.3. Nature 344: 540–541. [DOI] [PubMed] [Google Scholar]
14. Burek MJ, Oppenheim RW (1996). Programmed cell death in the developing nervous system. Brain Pathol 6: 427–446. [DOI] [PubMed] [Google Scholar]
15. Bürglen L, Amiel J, Viollet L, Lefebvre S, Burlet P, Clermont O, Raclin V, Landrieu P, Verloes A, Munnich A, Melki J. (1996) Survival motor neuron gene deletion in the arthrogryposis multiplex congenita‐spinal muscular atrophy association. J Clin Invest 98: 1130–1132. [DOI] [PMC free article] [PubMed] [Google Scholar]
16. Bürglen L, Lefebvre S, Clermont O, Burlet P, Viollet L, Cruaud C, Munnich A, Melki J (1996) Structure and organization of the human survival motor neurone (SMN) gene. Genomics 32: 479–482. [DOI] [PubMed] [Google Scholar]
17. Bürglen L, Seroz T, Miniou P, Lefebvre S, Burlet P, Munnich A, Pequignot EV, Egly JM, Melki J (1997) The gene encoding p44, a subunit of the transcription factor TFIIH, is involved in large‐scale deletions associated with Werdnig‐Hoffmann disease. Am J Hum Genet 60: 72–79. [PMC free article] [PubMed] [Google Scholar]
18. Burlet P, Bürglen L, Clermont O, Lefebvre S, Viollet L, Munnich A, Melki J (1996) Large scale deletions of the 5q13 region are specific to Werdnig‐Hoffmann disease. J Med Genet 33: 281–283. [DOI] [PMC free article] [PubMed] [Google Scholar]
19. Burlet P, Huber C, Bertrandy S, Ludosky MA, Zwaenepoel I, Clermont O, Roume J, Delezoide AL, Cartaud J, Munnich A, Lefebvre S (1998) The distribution of SMN protein complex in human fetal tissues and its alteration in spinal muscular atrophy. Hum Mol Genet 7: 1927–1933. [DOI] [PubMed] [Google Scholar]
20. Bussaglia E, Clermont O, Tizzano E, Lefebvre S, Bürglen L, Cruaud C, Urtizberea JA, Colomer J, Munnich A, Baiget M et al (1995) A frame‐shift deletion in the survival motor neuron gene in Spanish spinal muscular atrophy patients. Nat Genet 11: 335–337. [DOI] [PubMed] [Google Scholar]
21. Campbell L, Potter A, Ignatius J, Dubowitz V, Davies K (1997) Genomic variation and gene conversion in spinal muscular atrophy: implications for disease process and clinical phenotype. Am J Hum Genet 61: 40–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
22. Carter TA, Bonnemann CG, Wang CH, Obici S, Parano E, De Fatima Bonaldo M, Ross BM, Penchaszadeh GK, Mackenzie A, Soares MB, Kunkel LM, Gilliam TC (1997) A multicopy transcription repair gene, BTF2p44, maps to the SMA region and demonstrates SMA associated deletions. Hum Mol Genet 6: 229–236. [DOI] [PubMed] [Google Scholar]
23. Carvalho T, Almeida F, Calapez A, Lafarga M, Berciano MT, Carmo‐Fonseca M (1999) The spinal muscular atrophy disease gene product, SMN: A link between snRNP biogenesis and the Cajal (coiled) body. J Cell Biol 147: 715–728. [DOI] [PMC free article] [PubMed] [Google Scholar]
24. Chang JG, Jong YJ, Huang JM, Wang WS, Yang TY, Chang CP, Chen YJ, Lin SP (1995) Molecular basis of spinal muscular atrophy in Chinese. Am J Hum Genet 57: 1503–1505. [PMC free article] [PubMed] [Google Scholar]
25. Charroux B, Pellizzoni L, Perkinson RA, Shevchenko A, Mann M, Dreyfuss G (1999) Gemin3: A novel DEAD box protein that interacts with SMN, the spinal muscular atrophy gene product, and is a component of gems. J Cell Biol 147: 1181–1194. [DOI] [PMC free article] [PubMed] [Google Scholar]
26. Charroux B, Pellizzoni L, Perkinson RA, Yong J, Shevchenko A, Mann M, Dreyfuss G (2000) Gemin4. A novel component of the SMN complex that is found in both gems and nucleoli. J Cell Biol 148: 1177–1186. [DOI] [PMC free article] [PubMed] [Google Scholar]
27. Chou SM, Wang HS (1997) Aberrant glycosylation/phosphorylation in chromatolytic motoneurons of Werdnig‐Hoffmann disease. J Neurol Sci 152: 198–209. [DOI] [PubMed] [Google Scholar]
28. Cisterni C, Henderson CE, Aebisher P, Pettmann B, Deglon N (2000) Efficient gene transfer and expression of biologically active glial cell line‐derived neurotrophic factor in rat motoneurons transduced with lentiviral vectors. J Neurochem 74: 1820–1828. [DOI] [PubMed] [Google Scholar]
29. Clem RJ, Miller LK (1994) Control of programmed cell death by the baculovirus genes p35 and iap. Mol Cell Biol 14: 5212–5222. [DOI] [PMC free article] [PubMed] [Google Scholar]
30. Cobben JM, van der Steege G, Grootscholten P, De Visser M, Scheffer H, Buys CH (1995) Deletions of the survival motor neuron gene in unaffected siblings of patients with spinal muscular atrophy. Am J Hum Genet 57: 805–808. [PMC free article] [PubMed] [Google Scholar]
31. Coovert DD, Le TT, McAndrew PE, Strasswimmer J, Crawford TO, Mendell JR, Coulson SE, Androphy EJ, Prior TW, Burghes AH (1997) The survival motor neuron protein in spinal muscular atrophy. Hum Mol Genet 6: 1205–1214. [DOI] [PubMed] [Google Scholar]
32. Cork LC, Altschuler RJ, Bruha PJ, Morris JM, Lloyd DG, Loats HL, Griffin JW, Price DL (1989) Changes in neuronal size and neurotransmitter marker in hereditary canine spinal muscular atrophy. Lab Invest 61: 69–76. [PubMed] [Google Scholar]
33. Cork LC, Struble RG, Gold BG, DiCarlo C, Fahnestock KE, Griffin JW, Price DL (1989) Changes in size of motor axons in hereditary canine spinal muscular atrophy. Lab Invest 61: 333–342. [PubMed] [Google Scholar]
34. Crawford TO, Chaudhry V, Sladsky JT (1995) Lack of reinnervation in severe infantile spinal muscular atrophy. Ann Neurol 38: 539. [Google Scholar]
35. Crawford TO, Pardo CA (1996) The neurobiology of childhood spinal muscular atrophy. Neurobiol Dis 3:97–110. [DOI] [PubMed] [Google Scholar]
36. Daniels RJ, Suthers GK, Morrison KE, Thomas NH, Francis MJ, Mathew CG, Loughlin S, Heiberg A, Wood D, Dubowitz V, Davies KE (1992) Prenatal prediction of spinal muscular atrophy. J Med Genet 29: 165–170. [DOI] [PMC free article] [PubMed] [Google Scholar]
37. Dubowitz V (1999) Very severe spinal muscular atrophy (SMA type 0): an expanding clinical phenotype. Europ J Paediatr Neurol 3: 49–51. [DOI] [PubMed] [Google Scholar]
38. Duchen LW, Strich SJ (1968) An hereditary motor neurone disease with progressive denervation of muscle in the mouse: the mutant ‘wobbler’ (with an appendix by Falconer DS). J Neurol Neurosurg Psychiat 31: 535–542. [DOI] [PMC free article] [PubMed] [Google Scholar]
39. Echaniz‐Laguna A, Miniou P, Bartholdi D, Melki J (1999) The promoters of the survival motor neuron gene (SMN) and its copy (SMNc) share common regulatory elements. Am J Hum Genet 64: 1365–1370. [DOI] [PMC free article] [PubMed] [Google Scholar]
40. Eisen JS (1999) Patterning motoneurons in the vertebrate nervous system. Trends Neurosci 22: 321–326. [DOI] [PubMed] [Google Scholar]
41. Fidzianska A, Goebel HH, Warlo I (1990) Acute infantile spinal muscular atrophy. Muscle apoptosis as a proposed pathogenetic mechanism. Brain 113: 433–445. [DOI] [PubMed] [Google Scholar]
42. Fischer U, Liu Q, Dreyfuss G (1997) The SMN‐SIP1 complex has an essential role in spliceosomal snRNP biogenesis. Cell 90: 1023–1029. [DOI] [PubMed] [Google Scholar]
43. Fitzsimons RB, Hoh JFY (1981) Embryonic and foetal myosins in human skeletal muscle. The presence of foetal myosins in duchenne muscular dystrophy and infantile spinal muscular atrophy. J Neurol Sci 52: 367–384. [DOI] [PubMed] [Google Scholar]
44. Francis MJ, Nesbit MA, Theodosiou AM, Rodrigues NR, Campbell L, Christodoulou Z, Qureshi SJ, Porteous DJ, Brookes AJ, Davies KE (1995) Mapping of retrotransposon sequences in the unstable region surrounding the spinal muscular atrophy locus in 5q13. Genomics 27: 366–369. [DOI] [PubMed] [Google Scholar]
45. Frey D, Schneider C, Xu L, Borg J, Spooren W, Caroni P (2000) Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci 20: 2534–2542. [DOI] [PMC free article] [PubMed] [Google Scholar]
46. Frugier T, Tiziano FD, Cifuentes‐Diaz C, Miniou P, Roblot N, Dierich A, Le Meur M, Melki J (2000) Nuclear targeting defect of SMN lacking the C‐terminus in a mouse model of spinal muscular atrophy. Hum Mol Genet 9: 849–858. [DOI] [PubMed] [Google Scholar]
47. Garces A, Haase G, Airaksinen MS, Livet J, Filippi P, de Lapeyrière O (2000) GFRalpha 1 is required for development of distinct subpopulations of motoneuron. J Neurosci 20: 4992–5000. [DOI] [PMC free article] [PubMed] [Google Scholar]
48. Garces A, Nishimune H, Philippe JM, Pettmann B, de Lapeyriere O (2000) FGF9: a motoneuron survival factor expressed by medial thoracic and sacral motoneurons. J Neurosci Res 60: 1–9. [DOI] [PubMed] [Google Scholar]
49. Gennarelli M, Lucarelli M, Capon F, Pizzuti A, Merlini L, Angelini C, Novelli G, Dallapiccola B (1995) Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients. Biochem Biophys Res Commun 213: 342–348. [DOI] [PubMed] [Google Scholar]
50. Gilliam TC, Brzustowicz LM, Castilla LH, Lehner T, Penchaszadeh GK, Daniels RJ, Byth BC, Knowles J, Hislop JE, Shapira Y, Dubowitz V, Munsat TL, Ott J, Davies KE (1990) Genetic homogeneity between acute and chronic forms of spinal muscular atrophy. Nature 345: 823–825. [DOI] [PubMed] [Google Scholar]
51. Guettier‐Sigrist S, Coupin G, Braun S, Warter JM, Poindron P (1998) Muscle could be the therapeutic target in SMA treatment. J Neurosci Res 53: 663–669. [DOI] [PubMed] [Google Scholar]
52. Gurney ME, Pu H, Chiu AY, DalCanto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng H‐X, Chen W, Zhai P, Sufit RL, Siddique T (1994) Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264: 1772–1775. [DOI] [PubMed] [Google Scholar]
53. Haase G, Kennel P, Pettmann B, Vigne E, Akli S, Revah F, Schmalbruch H, Kahn A (1997) Gene therapy of a murine motor neuron disease using adenoviral vectors for neurotrophic factors. Nat Med 3: 429–436. [DOI] [PubMed] [Google Scholar]
54. Hahnen E, Forkert R, Marke C, Rudnik‐Schöneborn S, Schönling J, Zerres K, Wirth B (1995) Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy: evidence of homozygous deletions of the SMN gene in unaffected individuals. Hum Mol Genet 4: 1927–1933. [DOI] [PubMed] [Google Scholar]
55. Hahnen E, Schönling J, Rudnik‐Schöneborn S, Raschke H, Zerres K, Wirth B (1997) Missense mutations in exon 6 of the survival motor neuron gene in patients with spinal muscular atrophy (SMA). Hum Mol Genet 6: 821–825. [DOI] [PubMed] [Google Scholar]
56. Hanash A, Leguern E, Birouk N, Clermont O, Pouget J, Bouche P, Munnich A, Brice A, Melki J (1997) SMN gene analysis of the spinal form of Charcot‐Marie‐Tooth disease. J Med Genet 34: 507–508. [DOI] [PMC free article] [PubMed] [Google Scholar]
57. Hausmanowa‐Petrusewicz, I (1978) Spinal Muscular Atrophy. Infantile and Juvenile Type. US Dept of Commerce. National Technical Information Service. Springfield, Virginia 22161.
58. Hausmanowa‐Petrusewicz I, Fidzianska A, Niebrój‐Dobosz I, Strugalska MH (1980) Is Kugelberg‐Welander spinal muscular atrophy a fetal defect Muscle Nerve 3: 389–402. [DOI] [PubMed] [Google Scholar]
59. Hayashi M, Arai N, Murakami T, Yoshio M, Oda M, Matsuyama H (1998) A study of cell death in Werdnig Hoffmann disease brain. Neurosci Lett 243: 117–120. [DOI] [PubMed] [Google Scholar]
60. Henderson CE (1995) Neurotrophic factors as therapeutic agents in amyotrophic lateral sclerosis ‐ Potential and pitfalls In: Pathogenesis and Therapy of Amyotrophic Lateral Sclerosis, Serratrice GT and Munsat TL (eds). Vol. 68 pp. 235–240, Lippincott‐Raven, Philadelphia . [PubMed] [Google Scholar]
61. Henderson CE, Hauser SL, Huchet M, Dessi F, Hentati F, Taguchi T, Changeux J‐P, Fardeau M. (1987) Extracts of muscle biopsies from patients with spinal muscular atrophies inhibit neurite outgrowth from spinal neurons. Neurology 37: 1361–1364. [DOI] [PubMed] [Google Scholar]
62. Hottinger AF, Azzouz M, Deglon N, Aebischer P, Zurn AD (2000) Complete and long‐term rescue of lesioned adult motoneurons by lentiviral‐mediated expression of glial cell line‐derived neurotrophic factor in the facial nucleus. J Neurosci 20: 5587–5593. [DOI] [PMC free article] [PubMed] [Google Scholar]
63. Hsieh‐Li HM, Chang J‐G, Jong Y‐J, Wu M‐H, Wang NM, Tsai CH, Li H. (2000) A mouse model for spinal muscular atrophy. Nat Genet 24: 66–70. [DOI] [PubMed] [Google Scholar]
64. Ikemoto A, Hirano A, Matsumoto S, Akiguchi I, Kimura J (1996) Synaptophysin expression in the anterior horn of Werdnig‐ Hoffmann disease. J Neurol Sci 136: 94–100. [DOI] [PubMed] [Google Scholar]
65. Imai T, Minami R, Nagaoka M, Ishikawa Y, Kameda K, Okabe M, Matsumoto H (1990) Proximal and distal motor nerve conduction velocities in Werdnig‐Hoffmann disease. Pediatr Neurol 6: 82–86. [DOI] [PubMed] [Google Scholar]
66. Iwahashi H, Eguchi Y, Yasuhara N, Hanafusa T, Matsuzawa Y, Tsujimoto Y (1997) Synergistic anti‐apoptotic activity between Bcl‐2 and SMN implicated in spinal muscular atrophy. Nature 390: 413–417. [DOI] [PubMed] [Google Scholar]
67. Jablonka S, Schrank B, Kralewski M, Rossoll W, Sendtner M (2000) Reduced survival motor neuron (Smn) gene dose in mice leads to motor neuron degeneration: an animal model for spinal muscular atrophy type III. Hum Mol Genet 9: 341–346. [DOI] [PubMed] [Google Scholar]
68. Jones JM, Albin RL, Feldman EL, Simin K, Schuster TG, Dunnick WA, Collins JT, Chrisp CE, Taylor BA, Meisler MH (1993) mnd2: A new mouse model of inherited motor neuron disease. Genomics 16: 669–677. [DOI] [PubMed] [Google Scholar]
69. Jong Y‐J, Chang J‐G, Wu J‐R (1998). Large‐scale deletions in a Chinese infant associated with a variant form of Werdnig‐ Hoffmann disease. Neurology 51: 878–879. [DOI] [PubMed] [Google Scholar]
70. Kashihara Y, Kuno M, Miyata Y (1987) Cell death of axotomized motoneurones in neonatal rats, and its prevention by peripheral reinnervation. J Physiol (Lond) 386: 135–148. [DOI] [PMC free article] [PubMed] [Google Scholar]
71. Kato S, Hirano A (1990) Ubiquitin and phosphorylated neurofilament epitopes in ballooned neurons of the extraocular muscle nuclei in a case of Werdnig‐Hoffmann disease. Acta Neuropathol (Berl) 80: 334–337. [DOI] [PubMed] [Google Scholar]
72. Keir SD, Mitchell WJ, Feldman LT, Martin JR (1995) Targeting and gene expression in spinal cord motor neurons following intramuscular inoculation of an HSV‐1 vector. J Neurovirol 1: 259–267. [DOI] [PubMed] [Google Scholar]
73. Kennel PF, Finiels F, Revah F, Mallet J (1996) Neuromuscular function impairment is not caused by motor neurone loss in FALS mice: an electromyographic study. Neuroreport 7: 1427–1431. [DOI] [PubMed] [Google Scholar]
74. Korinthenberg R, Sauer M, Ketelsen U‐P, Hanemann CO, Stoll G, Graf M, Baborie A, Volk B, Wirth B, Rudnik‐Schöneborn S, Zerres K (1997) Congenital axonal neuropathy caused by deletions in the spinal muscular atrophy region. Ann Neurol 42: 364–368. [DOI] [PubMed] [Google Scholar]
75. Kuzuhara S, Chou SM (1981) Preservation of the phrenic motoneurons in Werdnig‐Hoffmann disease. Ann Neurol 9: 506–510. [DOI] [PubMed] [Google Scholar]
76. La Bella V, Kallenbach S, Pettmann B (2000) Expression and subcellular localization of two isoforms of the survival motor neuron protein in different cell types. J Neurosci Res 62: 346–356. [DOI] [PubMed] [Google Scholar]
77. Lefebvre S, Bürglen L, Reboullet S, Clermont O, Burlet P, Viollet L, Benichou B, Cruaud C, Millasseau P, Zeviani M, LePaslier D, Frézal J, Cohen D, Weissenbach J, Munnich A, Melki J (1995) Identification and characterization of a spinal muscular atrophy‐determining gene. Cell 80: 155–165. [DOI] [PubMed] [Google Scholar]
78. Lefebvre S, Burlet P, Liu Q, Bertrandy S, Clermont O, Munnich A, Dreyfuss G, Melki J (1997) Correlation between severity and SMN protein level in spinal muscular atrophy. Nat Genet 16: 265–269. [DOI] [PubMed] [Google Scholar]
79. Lieberman AR (1974) Some factors affecting retrograde neuronal responses to axonal lesions In: Bellairs R, Gray EG, eds. Essays on the nervous system. A festschrift for Professor JZ Young. Oxford : Clarendon Press, pp 71–105. [Google Scholar]
80. Liu Q, Dreyfuss G (1996) A novel nuclear structure containing the survival of motor neurons protein. Embo J 15: 3555–3565. [PMC free article] [PubMed] [Google Scholar]
81. Liu Q, Fischer U, Wang F, Dreyfuss G (1997) The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins. Cell 90: 1013–1021. [DOI] [PubMed] [Google Scholar]
82. Lorson CL, Androphy EJ (2000) An exonic enhancer is required for inclusion of an essential exon in the SMA‐determining gene SMN. Hum Mol Genet 9: 259–265. [DOI] [PubMed] [Google Scholar]
83. Lorson CL, Hahnen E, Androphy EJ, Wirth B (1999) A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci USA 96: 6307–6311. [DOI] [PMC free article] [PubMed] [Google Scholar]
84. Lubischer JL, Thompson WJ (1999) Neonatal partial denervation results in nodal but not terminal sprouting and a decrease in efficacy of remaining neuromuscular junctions in rat soleus muscle. J Neurosci 19: 8931–8944. [DOI] [PMC free article] [PubMed] [Google Scholar]
85. MacLeod MJ, Taylor JE, Lunt PW, Mathew CG, Robb SA (1999) Prenatal onset spinal muscular atrophy. Europ J Paediatr Neurol 3: 65–72. [DOI] [PubMed] [Google Scholar]
86. Matera AG (1999) Nuclear bodies: multifaceted subdomains of the interchromatin space. Trends Cell Biol 9: 302–309. [DOI] [PubMed] [Google Scholar]
87. Matera AG, Frey MR (1998) Coiled bodies and gems: Janus or gemini Am J Hum Genet 63: 317–321. [DOI] [PMC free article] [PubMed] [Google Scholar]
88. Matsumoto S, Goto S, Kusaka H, Imai T, Murakami N, Hashizume Y, Okazaki H, Hirano A (1993) Ubiquitin‐positive inclusion in anterior horn cells in subgroups of motor neuron diseases: a comparative study of adult‐onset amyotrophic lateral sclerosis, juvenile amyotrophic lateral sclerosis and Werdnig‐Hoffmann disease. J Neurol Sci 115: 208–213. [DOI] [PubMed] [Google Scholar]
89. McAndrew PE, Parsons DW, Simard LR, Rochette C, Ray PN, Mendell JR, Prior TW, Burghes AH (1997) Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am J Hum Genet 60: 1411–1422. [DOI] [PMC free article] [PubMed] [Google Scholar]
90. Melki J, Sheth P, Abdelhak S, Burlet P, Bachelot MF, Lathrop MG, Frézal J, Munnich A and the French Spinal Muscular Atrophy Investigators (1990b) Mapping of acute (type I) spinal muscular atrophy to chromosome 5q12‐q14. Lancet 336: 271–273. [DOI] [PubMed] [Google Scholar]
91. Melki J, Abdelhak S, Burlet P, Raclin V, Kaplan J, Spiegel R, Gilgenkrantz S, Philip N, Chauvet ML, Dumez Y, Briard ML, Frézal J, Munnich, A (1992) Prenatal prediction of Werdnig‐Hoffmann disease using linked polymorphic DNA probes. J Med Genet 29: 171–174. [DOI] [PMC free article] [PubMed] [Google Scholar]
92. Melki J, Abdelhak S, Sheth P, Bachelot MF, Burlet P, Marcadet A, Aicardi J, Barois A, Carriere JP, Fardeau M, Fontan D, Ponsot G, Billette T, Angelini C, Barbosa C, Ferriere G, Lanzi G, Ottolini A, Babron MC, Cohen D, Hanauer A, Clerget‐Darpoux F, Lathrop M, Munnich A, Frézal A (1990) Gene for chronic proximal spinal muscular atrophies maps to chromosome 5q. Nature 344: 767–8. [DOI] [PubMed] [Google Scholar]
93. Melki J, Lefebvre S, Bürglen L, Burlet P, Clermont O, Millasseau P, Reboullet S, Benichou B, Zeviani M, Le Paslier D, Cohen D, Weissenbach J, Munnich A (1994) De novo and inherited deletions of the 5q13 region in spinal muscular atrophies. Science 264: 1474–1477. [DOI] [PubMed] [Google Scholar]
94. Mercer EA, Korhonen L, Skoglosa Y, Olsson PA, Kukkonen JP, Lindholm D (2000) NAIP interacts with hippocalcin and protects neurons against calcium‐induced cell death through caspase‐3 dependent and ‐independent pathways. EMBO J 19: 3597–3607. [DOI] [PMC free article] [PubMed] [Google Scholar]
95. Messer A, Plummer J, Maskin P, Coffin JM & Frankel WN (1992) Mapping of the motor neuron degeneration (Mnd) gene, a mouse model of amyotrophic lateral sclerosis (ALS). Genomics 18: 797–802. [DOI] [PubMed] [Google Scholar]
96. Messer A, Strominger NL, Mazurkiewicz JE (1987) Histopathology of the late‐onset motor neuron degeneration (Mnd) mutant in the mouse. J Neurogen 4: 201–213. [PubMed] [Google Scholar]
97. Migheli A, Atzori C, Piva R, Tortarolo M, Girelli M, Schiffer D, Bendotti C (1999) Lack of apoptosis in mice with ALS. Nat Med 5: 966–967. [DOI] [PubMed] [Google Scholar]
98. Mitsumoto H, Ikeda K, Klinkosz B, Cedarbaum JM, Wong V, Lindsay RM (1994) Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF. Science 265: 1107–1110. [DOI] [PubMed] [Google Scholar]
99. Monani UR, Lorson CL, Parsons DW, Prior TW, Androphy EJ, Burghes AH, McPherson JD (1999) A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum Mol Genet 8: 1177–1183. [DOI] [PubMed] [Google Scholar]
100. Monani UR, McPherson JD, Burghes AH (1999) Promoter analysis of the human centromeric and telomeric survival motor neuron genes (SMNC and SMNT). Biochim Biophys Acta 1445: 330–336. [DOI] [PubMed] [Google Scholar]
101. Monani UR, Sendtner M, Coovert DD, Parsons DW, Andreassi C, Le TT, Jablonka S, Schrank B, Rossol W, Prior TW, Morris GE, Burghes AHM (2000) The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(^‐/‐) mice and results in a mouse with spinal muscular atrophy. Hum Mol Genet 9: 333–339. [DOI] [PubMed] [Google Scholar]
102. Moulard B, Salachas F, Chassande B, Briolotti V, Meininger V, Malafosse A, Camu W (1998) Association between centromeric deletions of the SMN gene and sporadic adult‐onset lower motor neuron disease. Ann Neurol 43: 640–644. [DOI] [PubMed] [Google Scholar]
103. Murayama S, Bouldin TW, Suzuki K (1991) Immunocytochemical and ultrastructural studies of Werdnig‐Hoffmann disease. Acta Neuropathol (Berl) 81: 408–417. [DOI] [PubMed] [Google Scholar]
104. Nicholson DW (2000) From bench to clinic with apoptosis based therapeutic agents. Nature 407: 810–816. [DOI] [PubMed] [Google Scholar]
105. Novak KD, Prevette D, Wang S, Gould TW, Oppenheim RW (2000) Hepatocyte growth factor/scatter factor is a neurotrophic survival factor for lumbar but not for other somatic motoneurons in the chick embryo. J Neurosci 20: 326–337. [DOI] [PMC free article] [PubMed] [Google Scholar]
106. Novelli G, Calza L, Amicucci P, Giardino L, Pozza M, Silani V, Pizzuti A, Gennarelli M, Piombo G, Capon F, Dallapiccola B (1997) Expression study of survival motor neuron gene in human fetal tissues. Biochem Mol Med 61: 102–106. [DOI] [PubMed] [Google Scholar]
107. Oppenheim RW, Houenou LJ, Parsadanian AS, Prevette D, Snider WD, Shen L (2000) Glial cell line‐derived neurotrophic factor and developing mammalian motoneurons: regulation of programmed cell death among motoneuron subtypes. J Neurosci 20: 5001–5011. [DOI] [PMC free article] [PubMed] [Google Scholar]
108. Orrell RW, Habgood JJ, De Belleroche JS, Lane RJ (1997) The relationship of spinal muscular atrophy to motor neuron disease: investigation of SMN and NAIP gene deletions in sporadic and familial ALS. J Neurol Sci 145: 55–61. [DOI] [PubMed] [Google Scholar]
109. Parboosingh JS, Meininger V, McKenna‐Yasek D, Brown RH, Jr. , Rouleau GA (1999) Deletions causing spinal muscular atrophy do not predispose to amyotrophic lateral sclerosis. Arch Neurol 56: 710–712. [DOI] [PubMed] [Google Scholar]
110. Pardo CA, Rabin BA, Palmer DN, Price DL (1994) Accumulation of the adenosine triphosphate synthase subunit C in the mnd mutant mouse. American Journal of Pathology 144: 829–835. [PMC free article] [PubMed] [Google Scholar]
111. Parsons DW, McAndrew PE, Allinson PS, Parker WD, Jr. , Burghes AH, Prior TW (1998) Diagnosis of spinal muscular atrophy in an SMN non‐deletion patient using a quantitative PCR screen and mutation analysis. J Med Genet 35: 674–676. [DOI] [PMC free article] [PubMed] [Google Scholar]
112. Parsons DW, McAndrew PE, Monani UR, Mendell JR, Burghes AH, Prior TW (1996) An 11 base pair duplication in exon 6 of the SMN gene produces a type I spinal muscular atrophy (SMA) phenotype: further evidence for SMN as the primary SMA‐determining gene. Hum Mol Genet 5: 1727–1732. [DOI] [PubMed] [Google Scholar]
113. Parsons DW, McAndrew PE, Iannaccone ST, Mendell JR, Burghes AH, Prior TW (1998) Intragenic telSMN mutations: frequency, distribution, evidence of a founder effect, and modification of the spinal muscular atrophy phenotype by cenSMN copy number. Am J Hum Genet 63: 1712–1723. [DOI] [PMC free article] [PubMed] [Google Scholar]
114. Pellizzoni L, Kataoka N, Charroux B, Dreyfuss G (1998) A novel function for SMN, the spinal muscular atrophy disease gene product, in pre‐mRNA splicing. Cell 95: 615–624. [DOI] [PubMed] [Google Scholar]
115. Perrelet D, Ferri A, MacKenzie AE, Smith GM, Korneluk RG, Liston P Sagot Y, Terrado J, Monnier D, Kato AC (2000) IAP family proteins delay motoneuron cell death in vivo. Eur J Neurosci 12: 2059–2067. [DOI] [PubMed] [Google Scholar]
116. Pollin MM, McHanwell S, Slater CR (1990) Loss of motor neurons from the median nerve motor nucleus of the mutant mouse ‘wobbler. J Neurocytol 19: 29–38. [DOI] [PubMed] [Google Scholar]
117. Rodrigues NR, Owen N, Talbot K, Ignatius J, Dubowitz V, Davies KE (1995) Deletions in the survival motor neuron gene on 5q13 in autosomal recessive spinal muscular atrophy. Hum Mol Genet 4: 631–634. [DOI] [PubMed] [Google Scholar]
118. Roy N, Mahadevan MS, McLean M, Shutler G, Yaraghi Z, Farahani R, Baird S, Besner‐Johnston A, Lefebvre C, Kang X, Salih M, Aubry H, Tamai K, Guan X, Ioannou P, Crawford TO, De Jong PJ, Surh L, Ikeda J‐E, Kornerluk RG, MacKenzie A (1995) The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 80: 167–178. [DOI] [PubMed] [Google Scholar]
119. Rudnik‐Schöneborn S, Lützenrath S, Borkowska J, Karwanska A, Hausmanowa‐Petrusewicz I, Zerres K (1998) Analysis of creatine kinase activity in 504 patients with proximal spinal muscular atrophy types I‐III from the point of view of progression and severity. Eur Neurol 39: 154–162. [DOI] [PubMed] [Google Scholar]
120. Sawchak JA, Benoff B, Sher JH, Shafiq SA (1990) Werdnig‐ Hoffmann disease: myosin isoform expression not arrested at prenatal stage of development. J Neurol Sci 95: 183–192. [DOI] [PubMed] [Google Scholar]
121. Scharf JM, Endrizzi MG, Wetter A, Huang S, Thompson TG, Zerres K, Dietrich WF, Wirth B, Kunkel LM (1998) Identification of a candidate modifying gene for spinal muscular atrophy by comparative genomics. Nat Genet 20: 83–86. [DOI] [PubMed] [Google Scholar]
122. Schmalbruch H (1984) Motoneuron death after sciatic nerve section in newborn rats. J Comp Neurol 224: 252–258. [DOI] [PubMed] [Google Scholar]
123. Schmalbruch H (1988) The effect of peripheral nerve injury on immature motor and sensory neurons and on muscle fibres.Possible relation to the histogenesis of Werdnig‐Hoffmann disease. Rev Neurol (Paris) 144: 721–729. [PubMed] [Google Scholar]
124. Schmalbruch H (1990) Growth and denervation response of skeletal muscle fibers of newborn rats. Muscle Nerve 13: 421–432. [DOI] [PubMed] [Google Scholar]
125. Schmalbruch H (1996) Natural killer cells and macrophages in immature denervated rat muscles. J Neuropath Exper Neurol 55: 310–319. [DOI] [PubMed] [Google Scholar]
126. Schmalbruch H, Haase G, Krarup C, Kahn A, Meisler MH, Jockusch H, Castelneau‐Ptakhine L (1999) Mouse models of motoneuron disease: a comparison of wr, pmn, SOD‐1 (G93A) and mnd‐2 with respect to assessment of therapeutic benefit. J Periph Nerv Syst 4: 166. [Google Scholar]
127. Schmalbruch H, Krarup C (1996) Animal models of neuropathy In: Hartung H‐P (ed) Peripheral Neuropathies, Part 2. London : Baillière Tindall. pp. 77–105. [PubMed] [Google Scholar]
128. Schmalbruch H, Skovgaard Jensen H‐J, Bjærg M, Kamieniecka Z, Kurland L (1991) A new mouse mutant with progressive motor neuronopathy. J Neuropath Exper Neurol 50: 192–204. [DOI] [PubMed] [Google Scholar]
129. Schrank B, Gotz R, Gunnersen JM, Ure JM, Toyka KV, Smith AG, Sendtner M (1997) Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc Natl Acad Sci USA 94: 9920–9925. [DOI] [PMC free article] [PubMed] [Google Scholar]
130. Selig S, Bruno S, Scharf JM, Wang CH, Vitale E, Gilliam TC, Kunkel LM (1995) Expressed cadherin pseudogenes are localized to the critical region of the spinal muscular atrophy gene. Proc Natl Acad Sci USA 92: 3702–3706. [DOI] [PMC free article] [PubMed] [Google Scholar]
131. Sendtner M, Gotz R, Holtmann B, Thoenen H (1997) Endogenous ciliary neurotrophic factor is a lesion factor for axotomized motoneurons in adult mice. J Neurosci 17: 6999–7006. [DOI] [PMC free article] [PubMed] [Google Scholar]
132. Sendtner M, Kreutzberg GW, Thoenen H. (1990) Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy. Nature 345: 440–441. [DOI] [PubMed] [Google Scholar]
133. Sendtner M, Schmalbruch H, Stöckli KA, Carroll P, Kreutzberg GW, Thoenen H. (1992) Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy. Nature 358: 502–504. [DOI] [PubMed] [Google Scholar]
134. Sendtner M, Stöckli KA, Thoenen H. (1992) Synthesis and localization of ciliary neurotrophic factor in the sciatic nerve of the adult rat after lesion and during regeneration. J Cell Biol 118: 139–148. [DOI] [PMC free article] [PubMed] [Google Scholar]
135. Smitt PAES, De Jong JMBV (1989). Animal models of amyotrophic lateral sclerosis and the spinal muscular atrophies. J Neurol Sci 91: 231–258. [DOI] [PubMed] [Google Scholar]
136. Soussi‐Yanicostas N, Ben Hamida C, Bejaoui K, Hentati F, Ben Hamida M, Butler‐Browne GS (1992) Evolution of muscle specific proteins in Werdnig‐Hoffman's disease. J Neurol Sci 109: 111–120. [DOI] [PubMed] [Google Scholar]
137. Talbot K, Ponting CP, Theodosiou AM, Rodrigues NR, Surtees R, Mountford R, Davies KE (1997) Missense mutation clustering in the survival motor neuron gene: a role for a conserved tyrosine and glycine rich region of the protein in RNA metabolism Hum Mol Genet 6: 497–500. [DOI] [PubMed] [Google Scholar]
138. Tews DS, Goebel HH (1997). Apoptosis‐related proteins in skeletal muscle fibers of spinal muscular atrophy. J Neuropathol Exper Neurol 56: 150–156. [DOI] [PubMed] [Google Scholar]
139. Thoenen H (1991) The changing scene of neurotrophic factors. Trends Neurosci 14: 165–170. [DOI] [PubMed] [Google Scholar]
140. Thomas NH, Dubowitz V (1994) The natural history of type I (severe) spinal muscular atrophy. Neuromusc Disord 4: 497–502. [DOI] [PubMed] [Google Scholar]
141. Thompson TG, DiDonato CJ, Simard LR, Ingraham SE, Burghes AH, Crawford TO, Rochette C, Mendell JR, Wasmuth JJ (1995) A novel cDNA detects homozygous microdeletions in greater than 50% of type I spinal muscular atrophy patients. Nat Genet 9: 56–62. [DOI] [PubMed] [Google Scholar]
142. Thompson W, Jansen JKS (1977) The extent of sprouting of remaining motor units in partly denervated immature and mature rat soleus muscle. Neurosci 2: 523–535. [DOI] [PubMed] [Google Scholar]
143. Towfighi J, Young RSK, Ward RM (1985) Is Werdnig‐Hoffmann disease a pure lower motor neuron disorder Acta Neuropathol (Berl) 65: 270–280. [DOI] [PubMed] [Google Scholar]
144. Trachtenberg JT, Thompson WJ (1996) Schwann cell apoptosis at developing neuromuscular junctions is regulated by glial growth factor. Nature 379: 174–177. [DOI] [PubMed] [Google Scholar]
145. Vajsar J, Balslev T, Ray PN, Siegel‐Bartelt J, Jay V (1998) Congenital cytoplasmic body myopathy with survival motor neuron gene deletion or Werdnig‐Hoffmann disease. Neurology 51: 873–875. [DOI] [PubMed] [Google Scholar]
146. van der Steege G, Grootscholten PM, van der Vlies P, Draaijers TG, Osinga J, Cobben JM, Scheffer H, Buys CH (1995) PCR‐based DNA test to confirm clinical diagnosis of autosomal recessive spinal muscular atrophy. Lancet 345: 985–986. [PubMed] [Google Scholar]
147. Velasco E, Valero C, Valero A, Moreno F, Hernandez‐Chico C (1996) Molecular analysis of the SMN and NAIP genes in Spanish spinal muscular atrophy (SMA) families and correlation between number of copies of cBCD541 and SMA phenotype. Hum Mol Genet 5: 257–263. [DOI] [PubMed] [Google Scholar]
148. Vrbova G, Greensmith L, Sieradzan K (1992) Motor neuron disease model. Nature 360: 216. [DOI] [PubMed] [Google Scholar]
149. Wang CH, Xu J, Carter TA, Ross BM, Dominski MK, Bellcross CA, Penchaszadeh GK, Munsat TL, Gilliam TC (1996) Characterization of survival motor neuron (SMNT) gene deletions in asymptomatic carriers of spinal muscular atrophy. Hum Mol Genet 5: 359–365. [DOI] [PubMed] [Google Scholar]
150. Wirth B, Herz M, Wetter A, Moskau S, Hahnen E, Rudnik Schöneborn S, Wienker T, Zerres K (1999) Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype phenotype correlation, and implications for genetic counseling. Am J Hum Genet 64: 1340–1356. [DOI] [PMC free article] [PubMed] [Google Scholar]
151. Xu DG, Crocker SJ, Doucet JP, St‐Jean M, Tamai K, Hakim AM, Ikeda JE, Liston P, Thompson CS, Korneluk RG, MacKenzie A, Robertson GS (1997) Elevation of neuronal expression of NAIP reduces ischemic damage in the rat hippocampus. Nat Med 3: 997–1004. [DOI] [PubMed] [Google Scholar]
152. Yamamoto Y, Livet J, Pollock RA, Garces A, Arce V, de Lapeyrière O, Henderson CE (1997) Hepatocyte growth factor (HGF/SF) is a muscle‐derived survival factor for a subpopulation of embryonic motoneurons. Development 124: 2903–2913. [DOI] [PubMed] [Google Scholar]
153. Yamanouchi Y, Yamanouchi H, Becker LE (1996) Synaptic alterations of anterior horn cells in Werdnig‐Hoffmann disease. Pediatr Neurol 15: 32–35. [DOI] [PubMed] [Google Scholar]
154. Zerres K, Rudnik‐Schöneborn S (1995) Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestions for a modification of existing classifications. Arch Neurol 52: 518–523. [DOI] [PubMed] [Google Scholar]
155. Zerres K, Rudnik‐Schöneborn S, Forrest E, Lusakowska A, Borkowska J, Hausmanowa‐Petrusewicz I (1997) A collaborative study on the natural history of childhood and juvenile onset proximal spinal muscular atrophy (type II and III SMA): 569 patients. J Neurol Sci 146: 67–72. [DOI] [PubMed] [Google Scholar]
156. Zhang M, Lorson CL, Androphy EJ, Zhou J (2000) Gene engineered cell lines for the studies of mRNA splicing of the survival of motor neuron genes. 30th Annual Meeting of the Society of Neuroscience, poster 91.17.

[b1] 1. Akli S, Caillaud C, Vigne E, Stratford PL, Poenaru L, Perricaudet M, Kahn A, Peschanski MR. (1993) Transfer of a foreign gene into the brain using adenovirus vectors. Nat Genet 3: 224–228. [DOI] [PubMed] [Google Scholar]

[b2] 2. Azzouz M, Hottinger A, Paterna JC, Zurn AD, Aebischer P, Bueler H (2000) Increased motoneuron survival and improved neuromuscular function in transgenic ALS mice after intraspinal injection of an adeno‐associated virus encoding Bcl‐2. Hum Mol Genet 9: 803–811. [DOI] [PubMed] [Google Scholar]

[b3] 3. Battaglia G, Princivalle A, Forti F, Lizier C, Zeviani M. (1997) Expression of the SMN gene, the spinal muscular atrophy determining gene, in the mammalian central nervous system. Hum Mol Genet 6: 1961–1971. [DOI] [PubMed] [Google Scholar]

[b4] 4. Béchade C, Rostaing P, Cisterni C, Kalisch R, La Bella V, Pettmann B, Triller A. (1999) Subcellular distribution of survival motor neuron (SMN) protein: possible involvement in nucleocytoplasmic and dendritic transport. Eur J Neurosci 11: 293–304. [DOI] [PubMed] [Google Scholar]

[b5] 5. Betz WJ, Caldwell JH, Ribchester RR (1980) The effects of partial denervation at birth on the development of muscle fibres and motor units in rat lumbrical muscle. J Physiol (Lond) 303: 265–279. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b6] 6. Biral D, Scarpini E, Angelini C, Salviati G, Margreth A (1989) Myosin heavy chain composition of muscle fibers in spinal muscular atrophy. Muscle Nerve 12: 43–51. [DOI] [PubMed] [Google Scholar]

[b7] 7. Bledsoe AW, Jackson CA, McPherson S, Morrow CD (2000) Cytokine production in motor neurons by poliovirus replicon vector gene delivery. Nat Biotechnol 18: 964–969. [DOI] [PubMed] [Google Scholar]

[b8] 8. Brahe C, Clermont O, Zappata S, Tiziano F, Melki J, Neri G. (1996) Frameshift mutation in the survival motor neuron gene in a severe case of SMA type I. Hum Mol Genet 5: 1971–1976. [DOI] [PubMed] [Google Scholar]

[b9] 9. Brännström T, Kellerth J‐O (1998) Changes in synaptology of adult cat spinal alpha‐motoneurons after axotomy. Exp Brain Res 118: 1–13. [DOI] [PubMed] [Google Scholar]

[b10] 10. Braun S, Croizat B, Lagrange MC, Warter JM, Poindron P (1995) Constitutive muscular abnormalities in culture in spinal muscular atrophy. Lancet 345:694–695. [DOI] [PubMed] [Google Scholar]

[b11] 11. Bronson RT, Lake BD, Cook S, Taylor S, Davisson MT (1993) Motor neuron degeneration in mice is a model of neuronal ceroid lipofuscinosis (Batten's disease). Annals of Neurology 33: 381–385. [DOI] [PubMed] [Google Scholar]

[b12] 12. Brown MC, Jansen JKS, Van Essen D (1976) Polyneural inervation of skeletal muscle in new‐born rats and its elimination during maturation. J Physiol (Lond) 261: 387–422. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b13] 13. Brzustowicz LM, Lehner T, Castilla LH, Penchaszadeh GK, Wilhelmsen KC, Daniels R, Davies KE, Leppert M, Ziter F, Wood D, Dubowitz V, Zerres K, Hausmanowa‐Petrusewicz I, Ott J, Munsat TL, Gilliam TC (1990) Genetic mapping of chronic childhood onset spinal muscular atrophy to chromosome 5q11.2–13.3. Nature 344: 540–541. [DOI] [PubMed] [Google Scholar]

[b14] 14. Burek MJ, Oppenheim RW (1996). Programmed cell death in the developing nervous system. Brain Pathol 6: 427–446. [DOI] [PubMed] [Google Scholar]

[b15] 15. Bürglen L, Amiel J, Viollet L, Lefebvre S, Burlet P, Clermont O, Raclin V, Landrieu P, Verloes A, Munnich A, Melki J. (1996) Survival motor neuron gene deletion in the arthrogryposis multiplex congenita‐spinal muscular atrophy association. J Clin Invest 98: 1130–1132. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b16] 16. Bürglen L, Lefebvre S, Clermont O, Burlet P, Viollet L, Cruaud C, Munnich A, Melki J (1996) Structure and organization of the human survival motor neurone (SMN) gene. Genomics 32: 479–482. [DOI] [PubMed] [Google Scholar]

[b17] 17. Bürglen L, Seroz T, Miniou P, Lefebvre S, Burlet P, Munnich A, Pequignot EV, Egly JM, Melki J (1997) The gene encoding p44, a subunit of the transcription factor TFIIH, is involved in large‐scale deletions associated with Werdnig‐Hoffmann disease. Am J Hum Genet 60: 72–79. [PMC free article] [PubMed] [Google Scholar]

[b18] 18. Burlet P, Bürglen L, Clermont O, Lefebvre S, Viollet L, Munnich A, Melki J (1996) Large scale deletions of the 5q13 region are specific to Werdnig‐Hoffmann disease. J Med Genet 33: 281–283. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b19] 19. Burlet P, Huber C, Bertrandy S, Ludosky MA, Zwaenepoel I, Clermont O, Roume J, Delezoide AL, Cartaud J, Munnich A, Lefebvre S (1998) The distribution of SMN protein complex in human fetal tissues and its alteration in spinal muscular atrophy. Hum Mol Genet 7: 1927–1933. [DOI] [PubMed] [Google Scholar]

[b20] 20. Bussaglia E, Clermont O, Tizzano E, Lefebvre S, Bürglen L, Cruaud C, Urtizberea JA, Colomer J, Munnich A, Baiget M et al (1995) A frame‐shift deletion in the survival motor neuron gene in Spanish spinal muscular atrophy patients. Nat Genet 11: 335–337. [DOI] [PubMed] [Google Scholar]

[b21] 21. Campbell L, Potter A, Ignatius J, Dubowitz V, Davies K (1997) Genomic variation and gene conversion in spinal muscular atrophy: implications for disease process and clinical phenotype. Am J Hum Genet 61: 40–50. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b22] 22. Carter TA, Bonnemann CG, Wang CH, Obici S, Parano E, De Fatima Bonaldo M, Ross BM, Penchaszadeh GK, Mackenzie A, Soares MB, Kunkel LM, Gilliam TC (1997) A multicopy transcription repair gene, BTF2p44, maps to the SMA region and demonstrates SMA associated deletions. Hum Mol Genet 6: 229–236. [DOI] [PubMed] [Google Scholar]

[b23] 23. Carvalho T, Almeida F, Calapez A, Lafarga M, Berciano MT, Carmo‐Fonseca M (1999) The spinal muscular atrophy disease gene product, SMN: A link between snRNP biogenesis and the Cajal (coiled) body. J Cell Biol 147: 715–728. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b24] 24. Chang JG, Jong YJ, Huang JM, Wang WS, Yang TY, Chang CP, Chen YJ, Lin SP (1995) Molecular basis of spinal muscular atrophy in Chinese. Am J Hum Genet 57: 1503–1505. [PMC free article] [PubMed] [Google Scholar]

[b25] 25. Charroux B, Pellizzoni L, Perkinson RA, Shevchenko A, Mann M, Dreyfuss G (1999) Gemin3: A novel DEAD box protein that interacts with SMN, the spinal muscular atrophy gene product, and is a component of gems. J Cell Biol 147: 1181–1194. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b26] 26. Charroux B, Pellizzoni L, Perkinson RA, Yong J, Shevchenko A, Mann M, Dreyfuss G (2000) Gemin4. A novel component of the SMN complex that is found in both gems and nucleoli. J Cell Biol 148: 1177–1186. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b27] 27. Chou SM, Wang HS (1997) Aberrant glycosylation/phosphorylation in chromatolytic motoneurons of Werdnig‐Hoffmann disease. J Neurol Sci 152: 198–209. [DOI] [PubMed] [Google Scholar]

[b28] 28. Cisterni C, Henderson CE, Aebisher P, Pettmann B, Deglon N (2000) Efficient gene transfer and expression of biologically active glial cell line‐derived neurotrophic factor in rat motoneurons transduced with lentiviral vectors. J Neurochem 74: 1820–1828. [DOI] [PubMed] [Google Scholar]

[b29] 29. Clem RJ, Miller LK (1994) Control of programmed cell death by the baculovirus genes p35 and iap. Mol Cell Biol 14: 5212–5222. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b30] 30. Cobben JM, van der Steege G, Grootscholten P, De Visser M, Scheffer H, Buys CH (1995) Deletions of the survival motor neuron gene in unaffected siblings of patients with spinal muscular atrophy. Am J Hum Genet 57: 805–808. [PMC free article] [PubMed] [Google Scholar]

[b31] 31. Coovert DD, Le TT, McAndrew PE, Strasswimmer J, Crawford TO, Mendell JR, Coulson SE, Androphy EJ, Prior TW, Burghes AH (1997) The survival motor neuron protein in spinal muscular atrophy. Hum Mol Genet 6: 1205–1214. [DOI] [PubMed] [Google Scholar]

[b32] 32. Cork LC, Altschuler RJ, Bruha PJ, Morris JM, Lloyd DG, Loats HL, Griffin JW, Price DL (1989) Changes in neuronal size and neurotransmitter marker in hereditary canine spinal muscular atrophy. Lab Invest 61: 69–76. [PubMed] [Google Scholar]

[b33] 33. Cork LC, Struble RG, Gold BG, DiCarlo C, Fahnestock KE, Griffin JW, Price DL (1989) Changes in size of motor axons in hereditary canine spinal muscular atrophy. Lab Invest 61: 333–342. [PubMed] [Google Scholar]

[b34] 34. Crawford TO, Chaudhry V, Sladsky JT (1995) Lack of reinnervation in severe infantile spinal muscular atrophy. Ann Neurol 38: 539. [Google Scholar]

[b35] 35. Crawford TO, Pardo CA (1996) The neurobiology of childhood spinal muscular atrophy. Neurobiol Dis 3:97–110. [DOI] [PubMed] [Google Scholar]

[b36] 36. Daniels RJ, Suthers GK, Morrison KE, Thomas NH, Francis MJ, Mathew CG, Loughlin S, Heiberg A, Wood D, Dubowitz V, Davies KE (1992) Prenatal prediction of spinal muscular atrophy. J Med Genet 29: 165–170. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b37] 37. Dubowitz V (1999) Very severe spinal muscular atrophy (SMA type 0): an expanding clinical phenotype. Europ J Paediatr Neurol 3: 49–51. [DOI] [PubMed] [Google Scholar]

[b38] 38. Duchen LW, Strich SJ (1968) An hereditary motor neurone disease with progressive denervation of muscle in the mouse: the mutant ‘wobbler’ (with an appendix by Falconer DS). J Neurol Neurosurg Psychiat 31: 535–542. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b39] 39. Echaniz‐Laguna A, Miniou P, Bartholdi D, Melki J (1999) The promoters of the survival motor neuron gene (SMN) and its copy (SMNc) share common regulatory elements. Am J Hum Genet 64: 1365–1370. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b40] 40. Eisen JS (1999) Patterning motoneurons in the vertebrate nervous system. Trends Neurosci 22: 321–326. [DOI] [PubMed] [Google Scholar]

[b41] 41. Fidzianska A, Goebel HH, Warlo I (1990) Acute infantile spinal muscular atrophy. Muscle apoptosis as a proposed pathogenetic mechanism. Brain 113: 433–445. [DOI] [PubMed] [Google Scholar]

[b42] 42. Fischer U, Liu Q, Dreyfuss G (1997) The SMN‐SIP1 complex has an essential role in spliceosomal snRNP biogenesis. Cell 90: 1023–1029. [DOI] [PubMed] [Google Scholar]

[b43] 43. Fitzsimons RB, Hoh JFY (1981) Embryonic and foetal myosins in human skeletal muscle. The presence of foetal myosins in duchenne muscular dystrophy and infantile spinal muscular atrophy. J Neurol Sci 52: 367–384. [DOI] [PubMed] [Google Scholar]

[b44] 44. Francis MJ, Nesbit MA, Theodosiou AM, Rodrigues NR, Campbell L, Christodoulou Z, Qureshi SJ, Porteous DJ, Brookes AJ, Davies KE (1995) Mapping of retrotransposon sequences in the unstable region surrounding the spinal muscular atrophy locus in 5q13. Genomics 27: 366–369. [DOI] [PubMed] [Google Scholar]

[b45] 45. Frey D, Schneider C, Xu L, Borg J, Spooren W, Caroni P (2000) Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci 20: 2534–2542. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b46] 46. Frugier T, Tiziano FD, Cifuentes‐Diaz C, Miniou P, Roblot N, Dierich A, Le Meur M, Melki J (2000) Nuclear targeting defect of SMN lacking the C‐terminus in a mouse model of spinal muscular atrophy. Hum Mol Genet 9: 849–858. [DOI] [PubMed] [Google Scholar]

[b47] 47. Garces A, Haase G, Airaksinen MS, Livet J, Filippi P, de Lapeyrière O (2000) GFRalpha 1 is required for development of distinct subpopulations of motoneuron. J Neurosci 20: 4992–5000. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b48] 48. Garces A, Nishimune H, Philippe JM, Pettmann B, de Lapeyriere O (2000) FGF9: a motoneuron survival factor expressed by medial thoracic and sacral motoneurons. J Neurosci Res 60: 1–9. [DOI] [PubMed] [Google Scholar]

[b49] 49. Gennarelli M, Lucarelli M, Capon F, Pizzuti A, Merlini L, Angelini C, Novelli G, Dallapiccola B (1995) Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients. Biochem Biophys Res Commun 213: 342–348. [DOI] [PubMed] [Google Scholar]

[b50] 50. Gilliam TC, Brzustowicz LM, Castilla LH, Lehner T, Penchaszadeh GK, Daniels RJ, Byth BC, Knowles J, Hislop JE, Shapira Y, Dubowitz V, Munsat TL, Ott J, Davies KE (1990) Genetic homogeneity between acute and chronic forms of spinal muscular atrophy. Nature 345: 823–825. [DOI] [PubMed] [Google Scholar]

[b51] 51. Guettier‐Sigrist S, Coupin G, Braun S, Warter JM, Poindron P (1998) Muscle could be the therapeutic target in SMA treatment. J Neurosci Res 53: 663–669. [DOI] [PubMed] [Google Scholar]

[b52] 52. Gurney ME, Pu H, Chiu AY, DalCanto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng H‐X, Chen W, Zhai P, Sufit RL, Siddique T (1994) Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264: 1772–1775. [DOI] [PubMed] [Google Scholar]

[b53] 53. Haase G, Kennel P, Pettmann B, Vigne E, Akli S, Revah F, Schmalbruch H, Kahn A (1997) Gene therapy of a murine motor neuron disease using adenoviral vectors for neurotrophic factors. Nat Med 3: 429–436. [DOI] [PubMed] [Google Scholar]

[b54] 54. Hahnen E, Forkert R, Marke C, Rudnik‐Schöneborn S, Schönling J, Zerres K, Wirth B (1995) Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy: evidence of homozygous deletions of the SMN gene in unaffected individuals. Hum Mol Genet 4: 1927–1933. [DOI] [PubMed] [Google Scholar]

[b55] 55. Hahnen E, Schönling J, Rudnik‐Schöneborn S, Raschke H, Zerres K, Wirth B (1997) Missense mutations in exon 6 of the survival motor neuron gene in patients with spinal muscular atrophy (SMA). Hum Mol Genet 6: 821–825. [DOI] [PubMed] [Google Scholar]

[b56] 56. Hanash A, Leguern E, Birouk N, Clermont O, Pouget J, Bouche P, Munnich A, Brice A, Melki J (1997) SMN gene analysis of the spinal form of Charcot‐Marie‐Tooth disease. J Med Genet 34: 507–508. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b57] 57. Hausmanowa‐Petrusewicz, I (1978) Spinal Muscular Atrophy. Infantile and Juvenile Type. US Dept of Commerce. National Technical Information Service. Springfield, Virginia 22161.

[b58] 58. Hausmanowa‐Petrusewicz I, Fidzianska A, Niebrój‐Dobosz I, Strugalska MH (1980) Is Kugelberg‐Welander spinal muscular atrophy a fetal defect Muscle Nerve 3: 389–402. [DOI] [PubMed] [Google Scholar]

[b59] 59. Hayashi M, Arai N, Murakami T, Yoshio M, Oda M, Matsuyama H (1998) A study of cell death in Werdnig Hoffmann disease brain. Neurosci Lett 243: 117–120. [DOI] [PubMed] [Google Scholar]

[b60] 60. Henderson CE (1995) Neurotrophic factors as therapeutic agents in amyotrophic lateral sclerosis ‐ Potential and pitfalls In: Pathogenesis and Therapy of Amyotrophic Lateral Sclerosis, Serratrice GT and Munsat TL (eds). Vol. 68 pp. 235–240, Lippincott‐Raven, Philadelphia . [PubMed] [Google Scholar]

[b61] 61. Henderson CE, Hauser SL, Huchet M, Dessi F, Hentati F, Taguchi T, Changeux J‐P, Fardeau M. (1987) Extracts of muscle biopsies from patients with spinal muscular atrophies inhibit neurite outgrowth from spinal neurons. Neurology 37: 1361–1364. [DOI] [PubMed] [Google Scholar]

[b62] 62. Hottinger AF, Azzouz M, Deglon N, Aebischer P, Zurn AD (2000) Complete and long‐term rescue of lesioned adult motoneurons by lentiviral‐mediated expression of glial cell line‐derived neurotrophic factor in the facial nucleus. J Neurosci 20: 5587–5593. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b63] 63. Hsieh‐Li HM, Chang J‐G, Jong Y‐J, Wu M‐H, Wang NM, Tsai CH, Li H. (2000) A mouse model for spinal muscular atrophy. Nat Genet 24: 66–70. [DOI] [PubMed] [Google Scholar]

[b64] 64. Ikemoto A, Hirano A, Matsumoto S, Akiguchi I, Kimura J (1996) Synaptophysin expression in the anterior horn of Werdnig‐ Hoffmann disease. J Neurol Sci 136: 94–100. [DOI] [PubMed] [Google Scholar]

[b65] 65. Imai T, Minami R, Nagaoka M, Ishikawa Y, Kameda K, Okabe M, Matsumoto H (1990) Proximal and distal motor nerve conduction velocities in Werdnig‐Hoffmann disease. Pediatr Neurol 6: 82–86. [DOI] [PubMed] [Google Scholar]

[b66] 66. Iwahashi H, Eguchi Y, Yasuhara N, Hanafusa T, Matsuzawa Y, Tsujimoto Y (1997) Synergistic anti‐apoptotic activity between Bcl‐2 and SMN implicated in spinal muscular atrophy. Nature 390: 413–417. [DOI] [PubMed] [Google Scholar]

[b67] 67. Jablonka S, Schrank B, Kralewski M, Rossoll W, Sendtner M (2000) Reduced survival motor neuron (Smn) gene dose in mice leads to motor neuron degeneration: an animal model for spinal muscular atrophy type III. Hum Mol Genet 9: 341–346. [DOI] [PubMed] [Google Scholar]

[b68] 68. Jones JM, Albin RL, Feldman EL, Simin K, Schuster TG, Dunnick WA, Collins JT, Chrisp CE, Taylor BA, Meisler MH (1993) mnd2: A new mouse model of inherited motor neuron disease. Genomics 16: 669–677. [DOI] [PubMed] [Google Scholar]

[b69] 69. Jong Y‐J, Chang J‐G, Wu J‐R (1998). Large‐scale deletions in a Chinese infant associated with a variant form of Werdnig‐ Hoffmann disease. Neurology 51: 878–879. [DOI] [PubMed] [Google Scholar]

[b70] 70. Kashihara Y, Kuno M, Miyata Y (1987) Cell death of axotomized motoneurones in neonatal rats, and its prevention by peripheral reinnervation. J Physiol (Lond) 386: 135–148. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b71] 71. Kato S, Hirano A (1990) Ubiquitin and phosphorylated neurofilament epitopes in ballooned neurons of the extraocular muscle nuclei in a case of Werdnig‐Hoffmann disease. Acta Neuropathol (Berl) 80: 334–337. [DOI] [PubMed] [Google Scholar]

[b72] 72. Keir SD, Mitchell WJ, Feldman LT, Martin JR (1995) Targeting and gene expression in spinal cord motor neurons following intramuscular inoculation of an HSV‐1 vector. J Neurovirol 1: 259–267. [DOI] [PubMed] [Google Scholar]

[b73] 73. Kennel PF, Finiels F, Revah F, Mallet J (1996) Neuromuscular function impairment is not caused by motor neurone loss in FALS mice: an electromyographic study. Neuroreport 7: 1427–1431. [DOI] [PubMed] [Google Scholar]

[b74] 74. Korinthenberg R, Sauer M, Ketelsen U‐P, Hanemann CO, Stoll G, Graf M, Baborie A, Volk B, Wirth B, Rudnik‐Schöneborn S, Zerres K (1997) Congenital axonal neuropathy caused by deletions in the spinal muscular atrophy region. Ann Neurol 42: 364–368. [DOI] [PubMed] [Google Scholar]

[b75] 75. Kuzuhara S, Chou SM (1981) Preservation of the phrenic motoneurons in Werdnig‐Hoffmann disease. Ann Neurol 9: 506–510. [DOI] [PubMed] [Google Scholar]

[b76] 76. La Bella V, Kallenbach S, Pettmann B (2000) Expression and subcellular localization of two isoforms of the survival motor neuron protein in different cell types. J Neurosci Res 62: 346–356. [DOI] [PubMed] [Google Scholar]

[b77] 77. Lefebvre S, Bürglen L, Reboullet S, Clermont O, Burlet P, Viollet L, Benichou B, Cruaud C, Millasseau P, Zeviani M, LePaslier D, Frézal J, Cohen D, Weissenbach J, Munnich A, Melki J (1995) Identification and characterization of a spinal muscular atrophy‐determining gene. Cell 80: 155–165. [DOI] [PubMed] [Google Scholar]

[b78] 78. Lefebvre S, Burlet P, Liu Q, Bertrandy S, Clermont O, Munnich A, Dreyfuss G, Melki J (1997) Correlation between severity and SMN protein level in spinal muscular atrophy. Nat Genet 16: 265–269. [DOI] [PubMed] [Google Scholar]

[b79] 79. Lieberman AR (1974) Some factors affecting retrograde neuronal responses to axonal lesions In: Bellairs R, Gray EG, eds. Essays on the nervous system. A festschrift for Professor JZ Young. Oxford : Clarendon Press, pp 71–105. [Google Scholar]

[b80] 80. Liu Q, Dreyfuss G (1996) A novel nuclear structure containing the survival of motor neurons protein. Embo J 15: 3555–3565. [PMC free article] [PubMed] [Google Scholar]

[b81] 81. Liu Q, Fischer U, Wang F, Dreyfuss G (1997) The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins. Cell 90: 1013–1021. [DOI] [PubMed] [Google Scholar]

[b82] 82. Lorson CL, Androphy EJ (2000) An exonic enhancer is required for inclusion of an essential exon in the SMA‐determining gene SMN. Hum Mol Genet 9: 259–265. [DOI] [PubMed] [Google Scholar]

[b83] 83. Lorson CL, Hahnen E, Androphy EJ, Wirth B (1999) A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci USA 96: 6307–6311. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b84] 84. Lubischer JL, Thompson WJ (1999) Neonatal partial denervation results in nodal but not terminal sprouting and a decrease in efficacy of remaining neuromuscular junctions in rat soleus muscle. J Neurosci 19: 8931–8944. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b85] 85. MacLeod MJ, Taylor JE, Lunt PW, Mathew CG, Robb SA (1999) Prenatal onset spinal muscular atrophy. Europ J Paediatr Neurol 3: 65–72. [DOI] [PubMed] [Google Scholar]

[b86] 86. Matera AG (1999) Nuclear bodies: multifaceted subdomains of the interchromatin space. Trends Cell Biol 9: 302–309. [DOI] [PubMed] [Google Scholar]

[b87] 87. Matera AG, Frey MR (1998) Coiled bodies and gems: Janus or gemini Am J Hum Genet 63: 317–321. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b88] 88. Matsumoto S, Goto S, Kusaka H, Imai T, Murakami N, Hashizume Y, Okazaki H, Hirano A (1993) Ubiquitin‐positive inclusion in anterior horn cells in subgroups of motor neuron diseases: a comparative study of adult‐onset amyotrophic lateral sclerosis, juvenile amyotrophic lateral sclerosis and Werdnig‐Hoffmann disease. J Neurol Sci 115: 208–213. [DOI] [PubMed] [Google Scholar]

[b89] 89. McAndrew PE, Parsons DW, Simard LR, Rochette C, Ray PN, Mendell JR, Prior TW, Burghes AH (1997) Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am J Hum Genet 60: 1411–1422. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b90] 90. Melki J, Sheth P, Abdelhak S, Burlet P, Bachelot MF, Lathrop MG, Frézal J, Munnich A and the French Spinal Muscular Atrophy Investigators (1990b) Mapping of acute (type I) spinal muscular atrophy to chromosome 5q12‐q14. Lancet 336: 271–273. [DOI] [PubMed] [Google Scholar]

[b91] 91. Melki J, Abdelhak S, Burlet P, Raclin V, Kaplan J, Spiegel R, Gilgenkrantz S, Philip N, Chauvet ML, Dumez Y, Briard ML, Frézal J, Munnich, A (1992) Prenatal prediction of Werdnig‐Hoffmann disease using linked polymorphic DNA probes. J Med Genet 29: 171–174. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b92] 92. Melki J, Abdelhak S, Sheth P, Bachelot MF, Burlet P, Marcadet A, Aicardi J, Barois A, Carriere JP, Fardeau M, Fontan D, Ponsot G, Billette T, Angelini C, Barbosa C, Ferriere G, Lanzi G, Ottolini A, Babron MC, Cohen D, Hanauer A, Clerget‐Darpoux F, Lathrop M, Munnich A, Frézal A (1990) Gene for chronic proximal spinal muscular atrophies maps to chromosome 5q. Nature 344: 767–8. [DOI] [PubMed] [Google Scholar]

[b93] 93. Melki J, Lefebvre S, Bürglen L, Burlet P, Clermont O, Millasseau P, Reboullet S, Benichou B, Zeviani M, Le Paslier D, Cohen D, Weissenbach J, Munnich A (1994) De novo and inherited deletions of the 5q13 region in spinal muscular atrophies. Science 264: 1474–1477. [DOI] [PubMed] [Google Scholar]

[b94] 94. Mercer EA, Korhonen L, Skoglosa Y, Olsson PA, Kukkonen JP, Lindholm D (2000) NAIP interacts with hippocalcin and protects neurons against calcium‐induced cell death through caspase‐3 dependent and ‐independent pathways. EMBO J 19: 3597–3607. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b95] 95. Messer A, Plummer J, Maskin P, Coffin JM & Frankel WN (1992) Mapping of the motor neuron degeneration (Mnd) gene, a mouse model of amyotrophic lateral sclerosis (ALS). Genomics 18: 797–802. [DOI] [PubMed] [Google Scholar]

[b96] 96. Messer A, Strominger NL, Mazurkiewicz JE (1987) Histopathology of the late‐onset motor neuron degeneration (Mnd) mutant in the mouse. J Neurogen 4: 201–213. [PubMed] [Google Scholar]

[b97] 97. Migheli A, Atzori C, Piva R, Tortarolo M, Girelli M, Schiffer D, Bendotti C (1999) Lack of apoptosis in mice with ALS. Nat Med 5: 966–967. [DOI] [PubMed] [Google Scholar]

[b98] 98. Mitsumoto H, Ikeda K, Klinkosz B, Cedarbaum JM, Wong V, Lindsay RM (1994) Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF. Science 265: 1107–1110. [DOI] [PubMed] [Google Scholar]

[b99] 99. Monani UR, Lorson CL, Parsons DW, Prior TW, Androphy EJ, Burghes AH, McPherson JD (1999) A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum Mol Genet 8: 1177–1183. [DOI] [PubMed] [Google Scholar]

[b100] 100. Monani UR, McPherson JD, Burghes AH (1999) Promoter analysis of the human centromeric and telomeric survival motor neuron genes (SMNC and SMNT). Biochim Biophys Acta 1445: 330–336. [DOI] [PubMed] [Google Scholar]

[b101] 101. Monani UR, Sendtner M, Coovert DD, Parsons DW, Andreassi C, Le TT, Jablonka S, Schrank B, Rossol W, Prior TW, Morris GE, Burghes AHM (2000) The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(^‐/‐) mice and results in a mouse with spinal muscular atrophy. Hum Mol Genet 9: 333–339. [DOI] [PubMed] [Google Scholar]

[b102] 102. Moulard B, Salachas F, Chassande B, Briolotti V, Meininger V, Malafosse A, Camu W (1998) Association between centromeric deletions of the SMN gene and sporadic adult‐onset lower motor neuron disease. Ann Neurol 43: 640–644. [DOI] [PubMed] [Google Scholar]

[b103] 103. Murayama S, Bouldin TW, Suzuki K (1991) Immunocytochemical and ultrastructural studies of Werdnig‐Hoffmann disease. Acta Neuropathol (Berl) 81: 408–417. [DOI] [PubMed] [Google Scholar]

[b104] 104. Nicholson DW (2000) From bench to clinic with apoptosis based therapeutic agents. Nature 407: 810–816. [DOI] [PubMed] [Google Scholar]

[b105] 105. Novak KD, Prevette D, Wang S, Gould TW, Oppenheim RW (2000) Hepatocyte growth factor/scatter factor is a neurotrophic survival factor for lumbar but not for other somatic motoneurons in the chick embryo. J Neurosci 20: 326–337. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b106] 106. Novelli G, Calza L, Amicucci P, Giardino L, Pozza M, Silani V, Pizzuti A, Gennarelli M, Piombo G, Capon F, Dallapiccola B (1997) Expression study of survival motor neuron gene in human fetal tissues. Biochem Mol Med 61: 102–106. [DOI] [PubMed] [Google Scholar]

[b107] 107. Oppenheim RW, Houenou LJ, Parsadanian AS, Prevette D, Snider WD, Shen L (2000) Glial cell line‐derived neurotrophic factor and developing mammalian motoneurons: regulation of programmed cell death among motoneuron subtypes. J Neurosci 20: 5001–5011. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b108] 108. Orrell RW, Habgood JJ, De Belleroche JS, Lane RJ (1997) The relationship of spinal muscular atrophy to motor neuron disease: investigation of SMN and NAIP gene deletions in sporadic and familial ALS. J Neurol Sci 145: 55–61. [DOI] [PubMed] [Google Scholar]

[b109] 109. Parboosingh JS, Meininger V, McKenna‐Yasek D, Brown RH, Jr. , Rouleau GA (1999) Deletions causing spinal muscular atrophy do not predispose to amyotrophic lateral sclerosis. Arch Neurol 56: 710–712. [DOI] [PubMed] [Google Scholar]

[b110] 110. Pardo CA, Rabin BA, Palmer DN, Price DL (1994) Accumulation of the adenosine triphosphate synthase subunit C in the mnd mutant mouse. American Journal of Pathology 144: 829–835. [PMC free article] [PubMed] [Google Scholar]

[b111] 111. Parsons DW, McAndrew PE, Allinson PS, Parker WD, Jr. , Burghes AH, Prior TW (1998) Diagnosis of spinal muscular atrophy in an SMN non‐deletion patient using a quantitative PCR screen and mutation analysis. J Med Genet 35: 674–676. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b112] 112. Parsons DW, McAndrew PE, Monani UR, Mendell JR, Burghes AH, Prior TW (1996) An 11 base pair duplication in exon 6 of the SMN gene produces a type I spinal muscular atrophy (SMA) phenotype: further evidence for SMN as the primary SMA‐determining gene. Hum Mol Genet 5: 1727–1732. [DOI] [PubMed] [Google Scholar]

[b113] 113. Parsons DW, McAndrew PE, Iannaccone ST, Mendell JR, Burghes AH, Prior TW (1998) Intragenic telSMN mutations: frequency, distribution, evidence of a founder effect, and modification of the spinal muscular atrophy phenotype by cenSMN copy number. Am J Hum Genet 63: 1712–1723. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b114] 114. Pellizzoni L, Kataoka N, Charroux B, Dreyfuss G (1998) A novel function for SMN, the spinal muscular atrophy disease gene product, in pre‐mRNA splicing. Cell 95: 615–624. [DOI] [PubMed] [Google Scholar]

[b115] 115. Perrelet D, Ferri A, MacKenzie AE, Smith GM, Korneluk RG, Liston P Sagot Y, Terrado J, Monnier D, Kato AC (2000) IAP family proteins delay motoneuron cell death in vivo. Eur J Neurosci 12: 2059–2067. [DOI] [PubMed] [Google Scholar]

[b116] 116. Pollin MM, McHanwell S, Slater CR (1990) Loss of motor neurons from the median nerve motor nucleus of the mutant mouse ‘wobbler. J Neurocytol 19: 29–38. [DOI] [PubMed] [Google Scholar]

[b117] 117. Rodrigues NR, Owen N, Talbot K, Ignatius J, Dubowitz V, Davies KE (1995) Deletions in the survival motor neuron gene on 5q13 in autosomal recessive spinal muscular atrophy. Hum Mol Genet 4: 631–634. [DOI] [PubMed] [Google Scholar]

[b118] 118. Roy N, Mahadevan MS, McLean M, Shutler G, Yaraghi Z, Farahani R, Baird S, Besner‐Johnston A, Lefebvre C, Kang X, Salih M, Aubry H, Tamai K, Guan X, Ioannou P, Crawford TO, De Jong PJ, Surh L, Ikeda J‐E, Kornerluk RG, MacKenzie A (1995) The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 80: 167–178. [DOI] [PubMed] [Google Scholar]

[b119] 119. Rudnik‐Schöneborn S, Lützenrath S, Borkowska J, Karwanska A, Hausmanowa‐Petrusewicz I, Zerres K (1998) Analysis of creatine kinase activity in 504 patients with proximal spinal muscular atrophy types I‐III from the point of view of progression and severity. Eur Neurol 39: 154–162. [DOI] [PubMed] [Google Scholar]

[b120] 120. Sawchak JA, Benoff B, Sher JH, Shafiq SA (1990) Werdnig‐ Hoffmann disease: myosin isoform expression not arrested at prenatal stage of development. J Neurol Sci 95: 183–192. [DOI] [PubMed] [Google Scholar]

[b121] 121. Scharf JM, Endrizzi MG, Wetter A, Huang S, Thompson TG, Zerres K, Dietrich WF, Wirth B, Kunkel LM (1998) Identification of a candidate modifying gene for spinal muscular atrophy by comparative genomics. Nat Genet 20: 83–86. [DOI] [PubMed] [Google Scholar]

[b122] 122. Schmalbruch H (1984) Motoneuron death after sciatic nerve section in newborn rats. J Comp Neurol 224: 252–258. [DOI] [PubMed] [Google Scholar]

[b123] 123. Schmalbruch H (1988) The effect of peripheral nerve injury on immature motor and sensory neurons and on muscle fibres.Possible relation to the histogenesis of Werdnig‐Hoffmann disease. Rev Neurol (Paris) 144: 721–729. [PubMed] [Google Scholar]

[b124] 124. Schmalbruch H (1990) Growth and denervation response of skeletal muscle fibers of newborn rats. Muscle Nerve 13: 421–432. [DOI] [PubMed] [Google Scholar]

[b125] 125. Schmalbruch H (1996) Natural killer cells and macrophages in immature denervated rat muscles. J Neuropath Exper Neurol 55: 310–319. [DOI] [PubMed] [Google Scholar]

[b126] 126. Schmalbruch H, Haase G, Krarup C, Kahn A, Meisler MH, Jockusch H, Castelneau‐Ptakhine L (1999) Mouse models of motoneuron disease: a comparison of wr, pmn, SOD‐1 (G93A) and mnd‐2 with respect to assessment of therapeutic benefit. J Periph Nerv Syst 4: 166. [Google Scholar]

[b127] 127. Schmalbruch H, Krarup C (1996) Animal models of neuropathy In: Hartung H‐P (ed) Peripheral Neuropathies, Part 2. London : Baillière Tindall. pp. 77–105. [PubMed] [Google Scholar]

[b128] 128. Schmalbruch H, Skovgaard Jensen H‐J, Bjærg M, Kamieniecka Z, Kurland L (1991) A new mouse mutant with progressive motor neuronopathy. J Neuropath Exper Neurol 50: 192–204. [DOI] [PubMed] [Google Scholar]

[b129] 129. Schrank B, Gotz R, Gunnersen JM, Ure JM, Toyka KV, Smith AG, Sendtner M (1997) Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc Natl Acad Sci USA 94: 9920–9925. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b130] 130. Selig S, Bruno S, Scharf JM, Wang CH, Vitale E, Gilliam TC, Kunkel LM (1995) Expressed cadherin pseudogenes are localized to the critical region of the spinal muscular atrophy gene. Proc Natl Acad Sci USA 92: 3702–3706. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b131] 131. Sendtner M, Gotz R, Holtmann B, Thoenen H (1997) Endogenous ciliary neurotrophic factor is a lesion factor for axotomized motoneurons in adult mice. J Neurosci 17: 6999–7006. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b132] 132. Sendtner M, Kreutzberg GW, Thoenen H. (1990) Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy. Nature 345: 440–441. [DOI] [PubMed] [Google Scholar]

[b133] 133. Sendtner M, Schmalbruch H, Stöckli KA, Carroll P, Kreutzberg GW, Thoenen H. (1992) Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy. Nature 358: 502–504. [DOI] [PubMed] [Google Scholar]

[b134] 134. Sendtner M, Stöckli KA, Thoenen H. (1992) Synthesis and localization of ciliary neurotrophic factor in the sciatic nerve of the adult rat after lesion and during regeneration. J Cell Biol 118: 139–148. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b135] 135. Smitt PAES, De Jong JMBV (1989). Animal models of amyotrophic lateral sclerosis and the spinal muscular atrophies. J Neurol Sci 91: 231–258. [DOI] [PubMed] [Google Scholar]

[b136] 136. Soussi‐Yanicostas N, Ben Hamida C, Bejaoui K, Hentati F, Ben Hamida M, Butler‐Browne GS (1992) Evolution of muscle specific proteins in Werdnig‐Hoffman's disease. J Neurol Sci 109: 111–120. [DOI] [PubMed] [Google Scholar]

[b137] 137. Talbot K, Ponting CP, Theodosiou AM, Rodrigues NR, Surtees R, Mountford R, Davies KE (1997) Missense mutation clustering in the survival motor neuron gene: a role for a conserved tyrosine and glycine rich region of the protein in RNA metabolism Hum Mol Genet 6: 497–500. [DOI] [PubMed] [Google Scholar]

[b138] 138. Tews DS, Goebel HH (1997). Apoptosis‐related proteins in skeletal muscle fibers of spinal muscular atrophy. J Neuropathol Exper Neurol 56: 150–156. [DOI] [PubMed] [Google Scholar]

[b139] 139. Thoenen H (1991) The changing scene of neurotrophic factors. Trends Neurosci 14: 165–170. [DOI] [PubMed] [Google Scholar]

[b140] 140. Thomas NH, Dubowitz V (1994) The natural history of type I (severe) spinal muscular atrophy. Neuromusc Disord 4: 497–502. [DOI] [PubMed] [Google Scholar]

[b141] 141. Thompson TG, DiDonato CJ, Simard LR, Ingraham SE, Burghes AH, Crawford TO, Rochette C, Mendell JR, Wasmuth JJ (1995) A novel cDNA detects homozygous microdeletions in greater than 50% of type I spinal muscular atrophy patients. Nat Genet 9: 56–62. [DOI] [PubMed] [Google Scholar]

[b142] 142. Thompson W, Jansen JKS (1977) The extent of sprouting of remaining motor units in partly denervated immature and mature rat soleus muscle. Neurosci 2: 523–535. [DOI] [PubMed] [Google Scholar]

[b143] 143. Towfighi J, Young RSK, Ward RM (1985) Is Werdnig‐Hoffmann disease a pure lower motor neuron disorder Acta Neuropathol (Berl) 65: 270–280. [DOI] [PubMed] [Google Scholar]

[b144] 144. Trachtenberg JT, Thompson WJ (1996) Schwann cell apoptosis at developing neuromuscular junctions is regulated by glial growth factor. Nature 379: 174–177. [DOI] [PubMed] [Google Scholar]

[b145] 145. Vajsar J, Balslev T, Ray PN, Siegel‐Bartelt J, Jay V (1998) Congenital cytoplasmic body myopathy with survival motor neuron gene deletion or Werdnig‐Hoffmann disease. Neurology 51: 873–875. [DOI] [PubMed] [Google Scholar]

[b146] 146. van der Steege G, Grootscholten PM, van der Vlies P, Draaijers TG, Osinga J, Cobben JM, Scheffer H, Buys CH (1995) PCR‐based DNA test to confirm clinical diagnosis of autosomal recessive spinal muscular atrophy. Lancet 345: 985–986. [PubMed] [Google Scholar]

[b147] 147. Velasco E, Valero C, Valero A, Moreno F, Hernandez‐Chico C (1996) Molecular analysis of the SMN and NAIP genes in Spanish spinal muscular atrophy (SMA) families and correlation between number of copies of cBCD541 and SMA phenotype. Hum Mol Genet 5: 257–263. [DOI] [PubMed] [Google Scholar]

[b148] 148. Vrbova G, Greensmith L, Sieradzan K (1992) Motor neuron disease model. Nature 360: 216. [DOI] [PubMed] [Google Scholar]

[b149] 149. Wang CH, Xu J, Carter TA, Ross BM, Dominski MK, Bellcross CA, Penchaszadeh GK, Munsat TL, Gilliam TC (1996) Characterization of survival motor neuron (SMNT) gene deletions in asymptomatic carriers of spinal muscular atrophy. Hum Mol Genet 5: 359–365. [DOI] [PubMed] [Google Scholar]

[b150] 150. Wirth B, Herz M, Wetter A, Moskau S, Hahnen E, Rudnik Schöneborn S, Wienker T, Zerres K (1999) Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype phenotype correlation, and implications for genetic counseling. Am J Hum Genet 64: 1340–1356. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b151] 151. Xu DG, Crocker SJ, Doucet JP, St‐Jean M, Tamai K, Hakim AM, Ikeda JE, Liston P, Thompson CS, Korneluk RG, MacKenzie A, Robertson GS (1997) Elevation of neuronal expression of NAIP reduces ischemic damage in the rat hippocampus. Nat Med 3: 997–1004. [DOI] [PubMed] [Google Scholar]

[b152] 152. Yamamoto Y, Livet J, Pollock RA, Garces A, Arce V, de Lapeyrière O, Henderson CE (1997) Hepatocyte growth factor (HGF/SF) is a muscle‐derived survival factor for a subpopulation of embryonic motoneurons. Development 124: 2903–2913. [DOI] [PubMed] [Google Scholar]

[b153] 153. Yamanouchi Y, Yamanouchi H, Becker LE (1996) Synaptic alterations of anterior horn cells in Werdnig‐Hoffmann disease. Pediatr Neurol 15: 32–35. [DOI] [PubMed] [Google Scholar]

[b154] 154. Zerres K, Rudnik‐Schöneborn S (1995) Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestions for a modification of existing classifications. Arch Neurol 52: 518–523. [DOI] [PubMed] [Google Scholar]

[b155] 155. Zerres K, Rudnik‐Schöneborn S, Forrest E, Lusakowska A, Borkowska J, Hausmanowa‐Petrusewicz I (1997) A collaborative study on the natural history of childhood and juvenile onset proximal spinal muscular atrophy (type II and III SMA): 569 patients. J Neurol Sci 146: 67–72. [DOI] [PubMed] [Google Scholar]

[b156] 156. Zhang M, Lorson CL, Androphy EJ, Zhou J (2000) Gene engineered cell lines for the studies of mRNA splicing of the survival of motor neuron genes. 30th Annual Meeting of the Society of Neuroscience, poster 91.17.

PERMALINK

Spinal Muscular Atrophy: Present State

Henning Schmalbruch

Georg Haase

Abstract

Full Text

References

ACTIONS

PERMALINK

RESOURCES

Cite

Add to Collections

PERMALINK

Spinal Muscular Atrophy: Present State

Henning Schmalbruch

Georg Haase

Abstract

Full Text

References

ACTIONS

PERMALINK

RESOURCES

Similar articles

Cited by other articles

Links to NCBI Databases